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Epidemiological studies have taken advantage of a number of strategies to monitor human
populations for mortality, incidence, and exposure to hazardous environmental agents. These
studies have been compromised by the lack of individual exposure assessment data that
precisely quantifies internal dose. As methods improve in analytical chemistry and molecular
biology, direct biological monitoring of exposed populations is possible. Biomarkers have been
developed and validated in exposed populations that quantify individual exposure, susceptibility,
and early markers of health effects and can be used to study relationships between exposures
and environmentally induced diseases. This paper provides background on the state of the art of
human populations monitoring and, through a series of case studies, provides examples of novel
biomarkers of exposure, susceptibility, and effect that highlight new opportunities for biomoni
toring. Prevention of human disease due to environmental contaminants can be accomplished by
implementing strategies such as those discussed to monitor exposures and early health effects
in human populations. - Environ Health Perspect 104(Suppl 3):479-483 (1996)
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Introduction and Background
Epidemiological studies intended to evaluate
the health significance of environmental
agents are usually compromised by the
lack ofquantitative exposure data for indi-
viduals within exposed populations.
Environmental monitoring data and esti-
mates constructed by modeling often rep-
resent the only exposure information
available; therefore, average population
exposure is often used in studies ofhealth
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effects. This method obviously is less pre-
cise in estimating health outcomes than
using specific measurement of individual
exposure doses in human effects studies.
Historically, epidemiological studies
have taken advantage of a number of
strategies to monitor human populations
for disease occurrence and exposure to haz-
ardous toxicants. As early as the 1800s,
reviews of death certificates were used to
describe the disease burden to populations
and to attempt to attribute lifestyle factors
or social ills to mortality. Communicable
disease reporting is also an example of
monitoring the population for a variety of
contagious diseases. The Centers for
Disease Control require physicians to
report selected communicable diseases to
monitor the levels ofpathogens and viruses
in the population. This reporting system is
used to target susceptible subpopulations
for immunization programs, to institute
preventive programs such as rabies vaccina-
tions, and to help identify new emerging
microbes such as the hantavirus. Human
population monitoring for chronic diseases
is also widespread in developed countries.
Scandinavian countries have developed a
unique resource for human population
monitoring by linking health insurance
identification numbers, census data, and
different hospital databases to create
disease registries. Cancer and birth defect
registries and other such surveillance sys-
tems have been used extensively in these
countries to study trends of incidence,
mortality, and health care utilization as
well as to launch many noted epidemio-
logical studies ofdisease etiology (1,2). In
the United States, the SEER (Surveillance,
Epidemiology, and End Results) network
provides a geographically diverse set of
population-based registries to monitor the
occurrence of cancer across the United
States. Many states have cancer and birth
defects registries that vary in coverage and
quality from hospital-based reporting to
population surveillance.
Systems for monitoring the human
population for exposures to environmental
agents are not as well established. Federal
agencies such as the U.S. Geological Survey
and the U.S. Environmental Protection
Agency routinely conduct environmental
monitoring of air, water, and soils for a
variety of polluting agents (3). These
environmental monitoring databases are
beginning to be used in conjunction with
health data to estimate human exposures
from these media. Powerful new computer
tools are available within geographic infor-
mation systems for spatially linking the
occurrence ofdisease cases with sources of
contamination in diverse populations.
The Agency for Toxic Substances and
Disease Registries (ATSDR) is mandated
by Congress to conduct health surveillance
programs of exposed populations. Many
exposure registries have been compiled to
facilitate this mandate. For example, sur-
veillance of persons exposed to trichloro-
ethylene, dioxin, benzene, and chromium
has been established as part ofthe ATSDR
National Exposure Registry. This surveil-
lance includes health outcomes in seven
priority areas: birth defects and reproduc-
tive disorders, cancer, immune function
disorders, kidney dysfunction, liver dys-
function, lung and respiratory diseases, and
neurotoxic disorders. Environmental moni-
toring data are reviewed at sites, mostly
Superfund sites, to identify areas where
exposure has taken place. Field studies are
carried out to identify cohorts of exposed
persons and enroll community residents.
Registry participants are contacted periodi-
cally to provide updated information about
health status (4).
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Exposure Assessment
Assessing human exposure to chemicals,
especially from Superfund sites, requires
not only understanding and applying
knowledge from a number ofscientific dis-
ciplines but also the gathering of large
amounts of data (5). It is necessary to
know how chemicals behave once they
have been deposited in these sites, how
they behave once they are released from the
sites, and how they behave once they come
into contact with humans. This complex
array ofinformation must be gathered for a
large variety ofdifferent chemicals and for
human populations that vary significantly
in important characteristics. Considering
the importance oflocal conditions, assess-
ments for each site must be location
specific and so must depend on emission,
transport, and exposure data gathered at
that particular site using the population at
greatest risk.
To characterize this complex situation,
generic models are being developed that
approximate the physicochemical behavior
ofchemicals and thus describe their envi-
ronmental distribution and fate. Further-
more, physiological pharmacokinetic
models developed in laboratory studies of
experimental animals and clinical investiga-
tions ofhumans are being applied to envi-
ronmental chemicals, concentrations, and
routes ofexposure in humans. Use ofsuch
information in human biomonitoring is
necessary to estimate exposure, including a
better understanding ofhuman variability.
Molecular Biomarkers
As methods improve in analytical chemistry
and molecular biology, direct biological
monitoring ofexposed populations is pos-
sible. Biomonitoring involves the use of
biological or molecular markers as indica-
tors signaling events in individuals exposed
to environmental chemicals. Therefore,
biological monitoring (i.e., acquisition of
exposure data through analysis ofcells, tis-
sues, or body fluids ofexposed people) may
lead to identification ofpotentially haz-
ardous exposures before adverse health
effects appear and to establish exposure
limits for minimizing the likelihood of
significant health risks.
A number of techniques have been
developed for monitoring human exposure
to environmental or occupational carcino-
gens. Among these methods are the mea-
surement of the chemical itself or its
metabolites in body fluids (e.g., serum or
urine) or the chemical bound to cellular
macromolecules including DNA and
protein, measurement of mutagens in
urine, and measurement ofearly biological
effects such as sister chromatid exchange
and chromosomal aberrations. The follow-
ing sections provide some case studies
of biomonitoring using state-of-the-art
molecular biology techniques that are avail-
able and have been validated for use in
environmental epidemiology studies.
DNAAdducts
Detecting carcinogen DNA adducts is
important in exposure monitoring and
identification ofearly lesions in the devel-
opment of cancer. Ultrasensitive and
highly specific methods for measuring the
DNA adducts associated with exposure to
hazardous chemicals, such as the known
human carcinogen vinyl chloride, have been
developed by Froment et al. (6). Major
advances have been made in the application
of gas chromatography/high resolution
mass spectrometry to the identification and
quantitation ofN2,3-ethenoguanine (EG),
the major promutagenic DNA adduct of
vinyl chloride. Routine measurements of
low fentomolar quantities ofEG can now
be made, and researchers have detected
endogenous EG adducts in DNA from
both human and animal liver samples (7).
Immunohistochemical techniques have
been developed using monoclonal antibod-
ies that recognize adducts to aflatoxin B,
(AFB1) (8). AFBI, a potent liver carcino-
gen in animals, has been associated with
increased incidence ofhepatocellular carci-
noma in Africa and Southeast Asia, espe-
cially in the presence ofhepatitis infection.
To better understand the role ofAFBI expo-
sure in human cancer incidence, biological
monitoring methods have been developed
to quantitate exposure on an individual
basis (9). It is now possible to measure
levels of the covalent adducts ofAFB1
on DNA and protein quickly and effec-
tively. Such measurements provide more
meaningful information on exposure and,
ultimately, on risk ofcancer development.
ProteinAdducts
Investigations into the utility ofdetection
and quantification of adducts formed
between environmental carcinogens and
the blood protein hemoglobin as a means
of monitoring carcinogen exposure have
resulted in several important findings. The
widely disseminated carcinogen 4-amino-
biphenyl is an important component of
cigarette smoke and is therefore encoun-
tered not only by smokers but also by non-
smokers through passive exposure to
environmental tobacco smoke. Studies
have revealed that levels of hemoglobin
adducts of4-aminobiphenyl accurately and
quantitatively reflect levels of exposure in
both smokers and nonsmokers (10). Adduct
levels also decline in a predictable manner
upon cessation ofsmoking. Importantly, in
studies ofsmokers using different types of
tobacco, adduct levels dearly reflected meta-
bolic capability for metabolizing the com-
pound in a manner that also correlated with
elevated risk of bladder cancer. Further,
studies ofnewborn infants ofsmoking and
nonsmoking mothers revealed the presence
of4-aminobiphenyl adducts in hemoglo-
bin ofthe infants at levels reflective ofthe
exposure history ofthe mothers. Thus, this
approach provides a sensitive and accurate
means of monitoring prenatal exposure to
maternal smoking metabolites and demon-
strates the technique's potential to monitor
exposures to awide variety ofcarcinogens.
Mutational Spectra
Analytical genetics is a component of
genetic toxicology, which applies biotech-
nology to the molecular events of muta-
tion. Understanding the mutational spectra
ofeach chemical or physical exposure (the
specificity and DNA context ofa collection
of mutations) is equivalent to identifying
fingerprints that can in turn be used to
identify the exposed populations.
A novel combination of technologies
has been developed that would allow the
detection and characterization of mutation
in an exposed population without the need
for either phenotypic selection, which
limits the number of detectable sites, or
DNA sequencing, which is extremely time
consuming. The principles of the new
approach developed by Coller and Thilly
(11) involve high fidelity polymerase
chain reaction (HiFi-PCR) and denaturing
gradient gel electrophoresis (DGGE).
Together, these techniques permit the pro-
duction ofa mutational profile that can be
expected to be unique for each agent. The
advantages provided by the combined
HiFi-PCR/DGGE are a) the potential for
automation, b) a need for only a small cell
sample, c) the potential to use any DNA
target without the need for a phenotypic
consequence, and d) this approach presents
the possibility of screening populations
rather than a few individuals.
Efforts are under way to improve on
the HiFi-PCR/DGGE assay by developing
an efficient and accurate PCR technology
and refining the DGGE technology. This
research will provide an improved approach
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to detect mutations in exposed popula-
tions. For example, research on a specific
gene sequence ofhuman lymphocyte cells
has demonstrated the applicability ofthese
kinds of studies to human cells in vitro.
Mutational spectra for known environ-
mental agents, including UV light and
benzo[a]pyrene diol epoxide (BPDE), as
well as other known mutagenic agents
(MNNG, ICR-191) and chromium have
been produced (12,13). In a study of
aflatoxin-exposed individuals in China,
mutational spectra analyses ofthe hprtgene
have shown mutants that have single base
substitutions occurring primarily at GC
base pairs (14). In vitro work in this same
study identified one strong mutational
hotspot in exon 3.
DNA-Protein Cross-linking
Investigators have been attempting to
understand DNA-protein cross-linking by
metals and their role in carcinogenesis.
Besides being a promising biomarker of
exposure, DNA-protein cross-linking is a
major form of genetic damage, one that
persists during cell proliferation. In investi-
gating the induction ofthis biomarker by
metals, investigators have identified the
structural protein actin as a major protein
cross-linked to the DNA by these agents.
Actin is also a major protein cross-linked to
the DNA by several other cross-linking
agents including UV light and cisplatin, a
cancer chemotherapeutic agent. Newstudies
have been performed with chromium and
nickel, and DNA-protein cross-links are
one ofthe primary lesions induced in cells
exposed to these metals. Because actin is
known to be important in the attachment
of DNA to the nuclear matrix, in sites for
DNA replication, and in the activation of
transcription, these studies may lead to
new insights into the mechanism of toxic-
ity and carcinogenicity ofmetals as well as
to other opportunities for biomonitoring
DNA-protein cross-linking chemicals.
Costa et al. (15-17) have evaluated the
feasibility ofusing the DNA-protein cross-
link assay in peripheral white blood cells
(WBC) to detect human exposure to both
chromium and nickel compounds in occu-
pational environments, specifically in
welders. Their results demonstrate that
welders have an elevation in this biomarker
related to chromium and nickel exposure in
the WBC and that the presence of this
lesion in the WBC signals its probable pres-
ence in other tissues as well, e.g., the lungs,
which presumably receive considerably
higher exposure than the peripheral blood
cells. The biomonitoring ofresidents living
in chromium-contaminated areas ofHudson
County, NewJersey, have also found ahigh
degree of DNA-protein cross-linking in
WBCs. Their results indicate that chromate
exposure has occurred in these residents;
there is concern regarding the high expo-
sure to chromium and also the long-term




There is evidence ofa link between envi-
ronmental air pollution and cancer-related
genetic damage in humans. Perera et al.
(18) looked at mothers and their offspring
in an industrial area having nonoccupa-
tional exposure to community airpollution.
The researchers studied two population
groups in Poland with differing degrees of
exposure to air pollution from coal com-
bustion. The highly exposed group lived in
the town of Gliwice, Upper Silesia, an
industrialized region characterized by high
rates ofcancer. The 49 unexposed controls
were from Biala Podlaska, a rural province
with roughly 10-fold lower levels of air
pollution than in Gliwice.
An array ofbiological markers ofmole-
cular and genetic damage, indicators that
signal events in individuals exposed to
environmental chemicals, including DNA
adducts, chromosomal mutations, and
activation of ras oncogene, was measured.
Perera et al. (18) found considerably
higher levels of DNA and chromosomal
damage in the exposed population com-
pared to the control population. A dou-
bling in the frequency of ras oncogene
activation also occurred in the exposed
group. This indicates that exposure to a
complex mixture ofpollutants was related
to molecular and genetic damage in
peripheral blood samples. Prior studies
have linked these biomarkers to increased
risk of cancer. Chromosomal mutations
and carcinogen-DNA adducts are also
highly relevant to reproductive damage.
The results of this investigation showed
statistically significant increases in all ofthe
biomarkers in the exposed group compared
to the controls. A relationship was observed
between DNA adducts and structural alter-
ations in the chromosomes. These studies
provide a molecular link between environ-
mental exposure and a genetic alteration
relevant to cancer and reproductive risk.
Ascertainment ofmolecular biomarkers in
these cohorts at an early age provides a
baseline set of parameters that can be
monitored as the studysubjects age.
PolyclorinatedBiphenyls
Advances in analytical chemistry have
created methods that detect smaller levels
of toxicants in smaller volumes of body
fluids and tissues. This is especially impor-
tant because environmental epidemiology
studies can be conducted as new hypothe-
ses and technologies emerge by analyzing
frozen specimens maintained in repository.
In the past, measurements of dioxins in
serum required nearly 100 ml to detect
levels in the part-per-billion range; now
part-per-trillion levels can be detected in
samples ofless that 10 ml (L.L. Needham,
personal communication).
Cohort studies ofchildren exposed to
polychlorinated biphenyls (PCBs) in utero
and in early life primarily through breast-
feeding have indicated perturbations in
growth and development (19). Monitoring
of human milk specimens has provided
estimates ofthe prevalence oforganochlo-
rine exposures due to the lipophilic nature
and biopersistence ofthe chemicals (20).
Currently, the detection of the PCBs
requires blood volumes in excess of 20 ml
and thus necessitates venipuncture. This
procedure is invasive, especially for infants
and small children. A method has been
developed by researchers that extracts the
urine ofinfants from specially prepared
cloth diapers and analyzes it for PCB con-
geners at the parts-per-trillion level. In a
pilot study offive nursing infants, each had
detectable levels ofPCBs in the urine, and
a significant correlation (r = 0.99) was
observed between urinary PCB concentra-
tion and duration ofbreast-feeding. The
method remains experimental, with further
refinement and field testing under way. It
may potentially enhance the opportunity
to biologically monitor infants and small
children, subgroups who are particularly
vulnerable to the effects of PCBs [E.F.
Fitzgerald, personal communication; (21)].
Genetic Susceptibility
Studies at the molecular level in humans
suggest that there is wide interindividual
variability, consistent with the observation
that disease risk is also highly variable
among individuals. Yet, in most cases, risk
assessment and subsequent regulation of
disease-causing chemicals are based on the
assumption that the general population is
homogeneous in its response. Therefore,
improved understanding of the nature
and significance of human variation in
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susceptibility and response has been
termed a priority environmentally induced
disease prevention. One ofthe goals ofthe
National Institute of Environmental
Health Sciences (NIEHS) is to attain a
better understanding ofinter- and intrain-
dividual variability pertaining to the
susceptibility ofthe human health effects
to environmental chemicals.
For a small percentage ofpersons who
develop cancer (less than 5%), inheritance
of a defective gene significantly increases
the risk for developing cancer. It is esti-
mated that 1 in 10 women will develop
breast cancer over the course ofher life-
time. Although several etiologic risk factors
have been identified for breast cancer,
women who have inherited a mutated copy
ofthe BRCAJ gene have approximately an
80% chance for developing breast or ovar-
ian cancer. Colon cancer affects 1 in 200,
but only for a small percentage ofthe pop-
ulation is there an inherited predisposition
for developing this cancer. The activation
ofseveral oncogenes is necessary to initiate
tumors, but for those individuals who
inherited the colon cancer gene, a defect in
the system to repair DNA allows for
random mutations to occur in oncogenes.
In the general population, it has been
observed that there are large interindividual
variations in a person's ability to respond
to DNA-damaging agents. Researchers
have noted greater than 5-fold variations in
excision repair in the general population;
among individuals who had a history of
cancer among first degree relatives, there
was a significant reduction in unscheduled
DNA synthesis compared to individuals
with no family history of cancer. In addi-
tion, interindividual variation in the
activity of 06-alkyguanine-DNA-methyl
transferase, an enzyme important in the
removal of 06-deoxyguanine has been
noted. The significance ofthese population
differences in repair enzyme activities in
relation to chemical exposure and cancer
risk is yet to be determined (22).
Perhaps the greatest advances in using
molecular tools to unravel gene-environ-
ment interactions have been in studying
the associations between exposure, poly-
morphisms in carcinogen-metabolizing
genes, and cancer risk. The enzymes
involved in carcinogen-metabolism fall
into two broad categories: Phase I enzymes,
which almost exclusively involve the
cytochrome P450 gene superfamily but
also include n-acetyl transferase and are
involved in metabolic activation, and
Phase II enzymes such as glutathione
S-transferases (GSTs), which are involved
in detoxification reactions and are consid-
ered protective pathways. Recent advances
in molecular DNA techniques have allowed
for the identification of polymorphisms
at the genetic level for several enzymes
important in carcinogen metabolism.
Bell et al. (23) have studied the associa-
tions between cigarette smoking, bladder
cancer, and the glutathione S-transferase
MI (GSTMJ) gene, which is polymorphic
in the population and absent in approxi-
mately one-half ofthe Caucasian popula-
tion. Their findings showed that persons
who smoked and had no GSTMI were at
greater risk for developing bladder cancer
than those individuals who smoked and
were GSTMI positive.
In an effort to combine molecular epi-
demiology and risk assessment, a number
of investigators are pursuing the molecular
characterization ofgenetic susceptibility of
the human cytochrome P450 system as a
potential biomonitor ofchemical exposure
and risk due to chemical exposure. A broad
array ofP450 genes has been characterized
in both humans and animals; consequent
to chemical exposures, these genes undergo
changes in expression level or pattern in a
variety of cell types. Genetic polymor-
phism in P450 expression may be an
important determinant in differences in an
individual's response to potential toxic
exposures. Novel strategies have recently
been developed for the specific and highly
sensitive detection ofP450 gene expression
in a variety ofhuman cells in culture and
in primary cells isolated directly from
human volunteers. These powerful assays,
using PCR-based technology (24) and
laser-activated fluorescence (25), that allow
for the detection ofP450-mediated enzy-
matic activities directly within individual
cells should provide expanded use of the
cytochrome P450 system as a biomarker of
chemical effect in humans exposed to
xenobiotic agents.
Studies at the molecular level in
humans suggest that there is wide inter-
individual variability in genetic parameters
and host characteristics which are consis-
tent with observations that disease risk is
also highly variable among segments ofthe
population. Yet in most cases, risk assess-
ment and subsequent regulation of
disease-causing chemicals are based on the
assumption that the general population is
homogeneous in its response. Success in
the prevention ofmorbidity from environ-
mentally induced diseases relies on the
ability to identify susceptible subgroups of
the population and target effective inter-
vention and prevention strategies to them.
Therefore, improved understanding ofthe
nature and significance ofhuman variation




There has been marked progress during the
past decade or so in the development of
techniques for biomonitoring in environ-
mental health sciences research. The initial
enthusiasm created by technological
advances has become tempered by the
recognition of methodological issues and
clarification of the role of biomarkers in
etiological research. The indisputable
strength ofexisting biomarkers lies in their
sensitivity to low biologically effective
doses of toxicant and their feasibility as
indicators of molecular host response.
Conversely, their limitations are related to
the process ofmeasurement.
Susceptibility factors can come into play
at almost any point between exposure and
disease outcome. Certainly differences in
individual absorption, distribution, metab-
olism, and repair all have the potential
to influence individual sensitivity to a par-
ticular environmental agent. In turn, these
specific differences may account for the
wide variations in incidence of disease
between and within groups of people.
Some ofthe most encouraging progress in
this area has been in the development of
biological markers of metabolism and of
DNA repair. The objective ofthese studies
should be to help elucidate the nature and
significance of inter- and intraindividual
variability in response to environmental
agents. Furthermore, such investigations are
an essential prerequisite to incorporating
biological markers into quantitative risk
assessment and epidemiological studies of
environmentally induced disease causation.
Methodological concerns such as repro-
ducibility, intra- and interlaboratory
variability, intra- and interindividual vari-
ability, source and exposure specificity,
and use of surrogate tissues are being
addressed by independent and collaborative
laboratories and investigators. Although
the laboratory component is important,
epidemiological study designs should
account for background exposures and
confounding variables. Combining mea-
surements ofdose or response (DNA and
protein adducts) with markers of sus-
ceptibility may be a way of minimizing
interindividual variability.
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It is obvious that there is a need to vali-
date existing and promising biomarkers in
tissues, individuals, and populations. A
concerted effort should be focused on
assessing inter- and intraindividual variabil-
ity as well as inter- and intralaboratory
variability (26). Selection of laboratory
measurement should be based on relevance
to the end point and to the research hypo-
thesis. Epidemiological study designs that
incorporate biomarkers must take into
account the methodological issues unique
to their application. The future ofbiomon-
itoring human populations for disease and
exposures lies in the discovery ofnew genes
for chronic diseases and in the develop-
ment of new biomarkers ofexposure and
susceptibility. The role ofspecimen reposi-
tories and laboratory networks is critical,
and a mechanism ofnetworking and fund-
ing mechanisms for such should be devel-
oped (27). Researchers conducting studies
of exposed individuals should bank any
unused blood, urine, tissues, and cells for
the promise offuture discoveries. It is there-
fore very important that future research
encourage cooperation, collaboration, and
communication between multidisciplinary
research teams (28). To facilitate this
process, regular interdisciplinary conferences
could encourage interactions, improve the
understanding of technical and logistic
problems, and clarify data interpretation.
Prevention of human disease due to
environmental contaminants can be accom-
plished by implementing strategies to
monitor exposures and early health effects
in human populations. New technologies
entwined with diligent surveillance offer
promise of further understanding of
the role of environmental exposure in
human disease.
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